Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schlack, W.
Right arrow Articles by Thamer, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlack, W.
Right arrow Articles by Thamer, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 76, Issue 6 860-867, Copyright © 1996 by The Board of Management and Trustees of the British Journal of Anaesthesia


LABORATORY INVESTIGATIONS

Effect of halothane on myocardial reoxygenation injury in the isolated rat heart

W. Schlack, M. Hollmann, J. Stunneck and V. Thamer
Institut fur Klinische Anaesthesiologie, Heinrich-Heine-Universitat, Dusseldorf, Germany; Physiologisches Institut I, Heinrich-Heine-Universitat, Dusseldorf, Germany

Several studies have reported a protective effect of halothane on myocardial injury in an ischaemia-reperfusion situation. It is unclear if the protection is a result of the haemodynamic effects of halothane or if halothane has a specific action on ischaemia or reperfusion pathomechanisms. To examine this question, we have used an isolated rat heart model where heart rate (300 beat min-1), ventricular volume and coronary flow are constant. Left ventricular developed pressure (LVDP) and release of creatine kinase (CK) were measured as variables of myocardial performance and cellular injury, respectively. Five control hearts were subjected to 35 min of low-flow (2 ml min-1) anoxic and substrate-free perfusion and were then perfused for 1 h with the oxygenated buffer. In the treatment groups, halothane 0.4 mmol litre-1 was added during the first 30 min of anoxic perfusion (n = 5) or during the first 30 min of reoxygenation (n = 5). In five additional hearts, the effect of halothane 0.4 mmol litre-1 was tested under normoxic conditions. Mean basal CK release was 0.29 (SEM 0.13) iu g-1 min-1 and LVDP was 105.5 (4.0) mm Hg. Under normoxic conditions, halothane reduced LVDP to 52.0 (2.6) mm Hg. In control hearts, the major cell injury occurred at the onset of reoxygenation (CK release increased to 149.1 (9.1) iu g-1 min-1) and functional recovery after 1 h of reoxygenation was poor (control LVDP, 14.2(2.)% of baseline). Halothane during anoxia attenuated myocardial injury only moderately (CK release 50.2(5.7) iu g-1 min-1) and LVDP recovered to 30.8(3.0)% (each P < 0.05 vs control). When halothane was administered at reoxygenation, CK release was reduced to 10.1 (0.9) iu g-1 min-1 and LVDP recovered to 69.4(4.9)% (each P < .05 vs control). We conclude that halothane not only attenuated ischaemic injury but had a specific protective action against reoxygenation injury.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
J. Frassdorf, S. De Hert, and W. Schlack
Anaesthesia and myocardial ischaemia/reperfusion injury
Br. J. Anaesth., July 1, 2009; 103(1): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Rodriguez-Sinovas, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler
Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium
J. Physiol., August 15, 2004; 559(1): 245 - 257.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, A. Rodriguez-Sinovas, and M. Ruiz-Meana
Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion
Cardiovasc Res, February 15, 2004; 61(3): 386 - 401.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Obal, B. Preckel, H. Scharbatke, J. Mullenheim, F. Hoterkes, V. Thamer, and W. Schlack
One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo
Br. J. Anaesth., December 1, 2001; 87(6): 905 - 911.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C Schafer, Y Ladilov, J Inserte, M Schafer, S Haffner, D Garcia-Dorado, and H.M Piper
Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury
Cardiovasc Res, August 1, 2001; 51(2): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Ebel, P. Lipfert, J. Fra{beta}dorf, B. Preckel, J. Mullenheim, V. Thamer, and W. Schlack
Lidocaine reduces ischaemic but not reperfusion injury in isolated rat heart
Br. J. Anaesth., June 1, 2001; 86(6): 846 - 852.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. M. Piper and D. Garcia-Dorado
Prime causes of rapid cardiomyocyte death during reperfusion
Ann. Thorac. Surg., November 1, 1999; 68(5): 1913 - 1919.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H.M. Piper, D. Garcna-Dorado, and M. Ovize
A fresh look at reperfusion injury
Cardiovasc Res, May 1, 1998; 38(2): 291 - 300.
[Full Text] [PDF]


Home page
CirculationHome page
B. Siegmund, W. Schlack, Y. V. Ladilov, C. Balser, and H. M. Piper
Halothane Protects Cardiomyocytes Against Reoxygenation-Induced Hypercontracture
Circulation, December 16, 1997; 96(12): 4372 - 4379.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.